Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Sclerostin in Vascular Calcification in Patients With Chronic Kidney Disease and Renal Transplantation

NCT04066855 is registered in ClinicalTrials.gov with Ahmed Faisal Mohamed Mohamed Saleh as lead sponsor.

NCT NCT04066855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04066855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Sclerostin in Vascular Calcification in Patients With Chronic Kidney Disease and Renal Transplantation
Lead sponsor
Ahmed Faisal Mohamed Mohamed Saleh
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2019
Completion date
September 30, 2020
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure, vascular calcification